The ONOO − reduction by Mn porphyrins catalyzed by ascorbate via Mn III
Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury
Fluorinated Mn(III)/(II)‐Porphyrin with Redox‐Responsive 1H and 19F Relaxation Properties - Pinto - 2023 - Chemistry – A European Journal - Wiley Online Library
Manganese superoxide dismutase, MnSOD and its mimics - ScienceDirect
An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins – From superoxide dismutation to H2O2-driven pathways - ScienceDirect
Molecules, Free Full-Text
Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury. - Abstract - Europe PMC
An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins – From superoxide dismutation to H2O2-driven pathways - ScienceDirect
The ONOO − reduction by Mn porphyrins catalyzed by ascorbate via Mn III
The ONOO − reduction by Mn porphyrins catalyzed by ascorbate via Mn III
Electrochemistry of Mn III TE-2-PyP 5 (Mn-2E 5 ) and Mn III Br 8
Reactions of HNO with Metal Porphyrins: Underscoring the Biological Relevance of HNO
Mn Porphyrin-Based Redox-Active Therapeutics
Proposed protective mechanism of Mn(III)porphyrins during
